Related Experiment Video
Updated: Feb 10, 2026

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System
Published on: October 26, 2010
Oral adverse events associated with anti-tumor necrosis factor-alpha therapies: using a large real-world dataset
Stella O Oyewole1, Adetokunbo B Olawuyi2, Osariemen Okhuaihesuyi3
1Department of Pathology, College of Medicine, University of Cincinnati, Cincinnati, OH.
Background:
Anti-tumor necrosis factor-alpha (anti-TNF-α) therapies are efficacious in managing immune-mediated inflammatory diseases, however, long-term use has been associated with notable adverse events. As patients use expands, understanding the spectrum of oral adverse events (OAEs) has become essential.
Materials And Methods:
We conducted a retrospective cohort study using the TriNetX research network. A 5‑year observation window identified patients prescribed anti‑TNF-α therapies. Patients with prior oral conditions, concurrent cancer therapies, or antiresorptive exposure were excluded. OAEs were categorized into xerostomia, mucosal disorders, infectious disorders, gingival hyperplasia, medication-related osteonecrosis of the jaw (MRONJ), and oral squamous cell carcinoma (OSCC). Propensity score matching (1:1, age/sex) compared anti‑TNF-α users with unexposed controls.
Results:
In a cohort of 1,645,751 individuals receiving anti‑TNF‑α therapy, OAEs were frequent, with oral lichenoid lesions (1.27%, 20,135), candidiasis (1.09%, 17,475), xerostomia (0.87%, 14,024), stomatitis (0.68%, 10,904), and oral herpes (0.39%, 6,343) most commonly observed. Less frequent events included MRONJ (0.01%, 173), gingival hyperplasia (0.02%, 285), and OSCC (0.07%, 1,074). Compared with the general population, anti‑TNF‑α therapy significantly increased the odds of most mucosal and infectious conditions (P < .001), though oral lichen planus showed no association. Interestingly, OSCC exhibited an inverse association (OR = 0.75, P < .0001), suggesting a potential protective effect.
Conclusion:
These findings highlight the importance of routine oral health surveillance and robust pharmacovigilance amongst patients on anti‑TNF-α therapies.
Insights
Anti-tumor necrosis factor-alpha (anti-TNF-α) therapies are linked to increased oral adverse events like mucosal and infectious disorders. However, these treatments may surprisingly reduce the risk of oral squamous cell carcinoma (OSCC).
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- Anti-tumor necrosis factor-alpha (anti-TNF-α) therapies are crucial for immune-mediated inflammatory diseases.
- Long-term anti-TNF-α use is associated with adverse events, necessitating understanding of oral adverse events (OAEs).
Purpose of the Study:
- To investigate the spectrum and frequency of OAEs in patients using anti-TNF-α therapies.
- To compare the incidence of OAEs between anti-TNF-α users and non-users.
Main Methods:
- Retrospective cohort study using the TriNetX research network over 5 years.
- Exclusion of patients with prior oral conditions, concurrent cancer therapies, or antiresorptive exposure.
- Propensity score matching (1:1, age/sex) to compare anti-TNF-α users with unexposed controls.
Main Results:
- Anti-TNF-α therapy was associated with increased odds of mucosal and infectious OAEs (e.g., oral lichenoid lesions, candidiasis, xerostomia).
- Oral lichen planus showed no association with anti-TNF-α therapy.
- Oral squamous cell carcinoma (OSCC) showed an inverse association (OR=0.75, P < .0001), suggesting a potential protective effect.
Conclusions:
- Routine oral health surveillance is essential for patients on anti-TNF-α therapies.
- Robust pharmacovigilance is crucial to monitor OAEs associated with anti-TNF-α use.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Integration of Synaptic Events
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...

